MLMagdalena Lipczyńska

Magdalena Lipczyńska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Magdalena Lipczyńska has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transition from paediatric to adult congenital heart disease care in Central and South-Eastern Europe: current practices and opportunities for improvement

    by Alexandra Arvanitaki, Katja Prokšelj, Iveta Šimkova, Irena Ivanac Vranešić, Agnese Strenge, Monika Komar, Magdalena Lipczynska, Anna Kaneva, Lina Gumbiene, Petra Antonova, et al.

    Aims: Transition from paediatric to adult congenital heart disease (ACHD) care is a critical determinant of lifelong disease management for individuals with congenital heart disease (CHD). However, structured transition programmes remain inconsistently implemented, and data are lacking on current practices in Central and South-Eastern European (CESEE) countries. This study aimed to evaluate existing transition practices across CESEE and to identify opportunities to improve the development and implementation of structured programmes. Methods and results: An online questionnaire was distributed to centres involved in CHD care across CESEE countries. The survey assessed centre characteristics, transition services, transfer processes, and development priorities. Responses from 60 healthcare CHD professionals representing 43 centres in 21 countries were analysed. A formal ACHD service was reported in 29 (67%) of 43 centres, mostly established after the year 2000 (72%), caring for a median of 1500 (interquartile range 782–4000) patients with ACHD. Overall, only 10 (23%) centres reported having a formal transition programme. Transition counselling was typically delivered in a single outpatient visit, commonly involving paediatric and adult CHD physicians, but rarely nurses and psychosocial professionals (20% each). Structured transfer processes were inconsistently implemented, and only half of the centres monitored non-attendance at initial adult visits. In centres without formal programmes, informal counselling largely occurred at the final paediatric or first adult visit, relying on patient self-referral, and lacking follow-up. Conclusion: Formal transition programmes remain limited across CESEE ACHD centres. Standardized clear pathways, investment in dedicated transition clinics, and trained workforce are needed to improve continuity of care for adolescents with CHD.

  • Open Access

    Ciąża wysokiego ryzyka u pacjentki ze złożoną wrodzoną wadą serca po licznych interwencjach

    by Magdalena Lipczyńska

    Prezentowany przypadek dotyczy przebiegu ciąży u 31-letniaj pacjentki z rzadką wadą wrodzoną serca stanowiącą ok 0.5% wszystkich wad wrodzonych. Była to ciąża wysokiego ryzyka (III klasa wg mWHO) powikłana niewydolnością serca. Poród przez cięcie cesarskie odbył się w 31 tygodniu...

  • Predictors of COVID-19 outcomes in adult congenital heart disease patients — anatomy versus function

    by Magdalena Lipczyńska, Ewa Kowalik, Magdalena Kumor, Beata Kuśmierczyk-Droszcz, Anna W Wójcik, Elżbieta K Biernacka, Piotr Hoffman

    Background: It is unclear whether patients with adult congenital heart disease (ACHD) should be considered as an increased risk population with poor outcomes when suffering from COVID-19. Aims:This study aimed to collect clinical outcome data and to identify risk factors of a complicated course of COVID-19 among ACHD patients. Methods: Among all outpatients who came to medical attention via telemedicine or direct physician contact at our institution between September 1, 2020 and March 31, 2021, we included all with a COVID-19 diagnosis. The incidence of COVID-19, a clinical course of the disease, and outcome were determined. Results: One hundred and four (8.7%) out of 1 197 patients who were seen at our outpatient clinic for ACHD patients met the definition of COVID-19. Most of them reported a mild course of COVID-19 (99 [95.5%]). Five patients (4.5%) experienced severe symptoms and needed hospitalization. Two patients (1.9% of all with a confirmed diagnosis, 40% with severe infection) died. In the multivariable analysis, decreased systemic ventricular systolic function and any significant valve stenosis were predictors of a complicated disease course. Conclusions:Our study confirmed previous results showing that a physiology-based model, rather than an anatomy-based model, better predicted COVID-19 outcomes among ACHD patients, which is of importance for patients and healthcare providers during the COVID-19 pandemic.


  • Response to: ‘Contemporary management and outcomes in congenitally corrected transposition of the great arteries’ by Kutty et al

    by Magdalena Lipczynska, Ewa Kowalik, Anna Klisiewicz, Piotr Marian Hoffman, Piotr Szymanski

    To the Editor We read, with great interest, the recent review of contemporary management and outcomes in congenitally corrected transposition of the great arteries (ccTGA) by Kutty et al .1 The authors mainly focused on surgical management of ccTGA, nearly omitting pharmacotherapy and general prevention strategies. However, in our experience, pharmacotherapy is effective in properly selected patients …


  • Open Access

    Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries

    by Magdalena Lipczyńska, Piotr Szymański, Magdalena Kumor, Anna Klisiewicz, Piotr Hoffman

    Myocardial fibrosis is a potential pathophysiological mechanism leading to systemic right ventricular (SRV) deterioration. We hypothesize that circulating levels of collagen deposition markers are elevated in patients with SRV remodeling and this elevation may have a predictive value. We prospectively evaluated 56 patients with D-TGA after the atrial switch procedure (mean age 25.6 ± 4.8, range 18–37 years; 67% males). Serum levels of procollagen type III amino-terminal propeptide (PIIINP), collagen type I carboxy-terminal telopeptide (CITP), procollagen type I N-terminal propeptide (PINP), matrix metalloproteinase (MMP 1, MMP 9) and a tissue inhibitor of matrix metalloproteinase (TIMP 1) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) were measured and compared with healthy controls. The relationship between these serum markers, echocardiographic and cardiac magnetic resonance parameters and the outcome at a follow-up of 61 months (range, 24–85 months) was determined. Compared with the healthy control group, the study group had significantly higher levels of TIMP1, PIIINP, CITP, PINP and NT-pro-BNP (p<0.05, each). The levels of PIIINP and CITP were significantly higher among patients with an SRV mass index above the mean value. The level of PIIINP was significantly higher among patients with an SRV EDV index above the mean value. CITP was significantly elevated in SRV late gadolinium enhanced (LGE) positive patients, compared to patients without SRV LGE. MMP9 and TIMP1 predicted an adverse clinical outcome on univariate Cox proportional hazard survival analysis in addition to well proven predictors of outcome (SRV EF and NYHA). We demonstrated a pattern of altered collagen turnover adversely related with the indices of SRV remodeling and an adverse clinical outcome in patients with SRV.


  • Pregnancy in women with complete transposition of the great arteries following the atrial switch procedure. A study from three of the largest Adult Congenital Heart Disease centers in Poland

    by Magdalena Lipczyńska, Piotr Szymański, Olga Trojnarska, Lidia Tomkiewicz-Pająk, Bronisława Pietrzak, Anna Klisiewicz, Magdalena Kumor, Piotr Podolec, Piotr Hoffman

    Objective: We sought to identify maternal/neonatal and cardiovascular complications in pregnant women with complete transposition of great arteries (D-TGA) following atrial switch. Methods: Clinical records of all women with D-TGA after the Mustard/Senning (M/S) operation who were followed at the three largest Adult Congenital Heart Disease (ACHD) centers in Poland were reviewed. Results: Fifteen of the fifty-nine women followed had a total of 24 pregnancies, including two spontaneous miscarriages. Twenty-two pregnancies (92%) resulted in a live birth, 91% were by cesarean section. During 5 (23%) of the 22 completed pregnancies obstetric complications were observed (one gestational diabetes, one hypertension in pregnancy, one placenta increta and two preterm labors). The mean pregnancy duration was 37.2 weeks (range: 26–41 weeks).We observed one neonatal death due to extreme prematurity. Six (25%) children had a birth weight of ≤2500 g. None of women had severe cardiac complications during pregnancy nor in the postpartum period. Conclusions: In our study, we demonstrated a large number of obstetric complications and low birth weight in the presence of a systemic right ventricle. However, from a cardiologist’s point of view pregnancy after the M/S operation was well-tolerated and relatively safe.


  • Global Longitudinal Strain May Identify Preserved Systolic Function of the Systemic Right Ventricle

    by Magdalena Lipczyńska, Piotr Szymański, Magdalena Kumor, Anna Klisiewicz, Łukasz Mazurkiewicz, Piotr Hoffman


  • Clinical Settings Leading to Presystolic Tricuspid Regurgitation

    by Piotr Szymański, Magdalena Lipczyńska, Anna Klisiewicz, Piotr Hoffman

    Few studies describe diastolic (presystolic) tricuspid regurgitation (DTR) mainly in the context of atrioventricular conduction abnormalities. Little is known about its occurrence in the other clinical settings.


    • 1 January 2012
      • Vol. 70  (10) , 1003-8

    Detection of heart failure at a primary care practice in a small town in Central Poland.

    by Magdalena Lipczyńska, Piotr Szymański, Anna Klisiewicz, Piotr Hoffman

    Heart failure (HF) is commonly misdiagnosed, and the validity of diagnosis in primary care is poor. According to the guidelines, an electrocardiogram, a chest X-ray and a standard echocardiogram should be obtained and the level of B-type natriuretic peptide (BNP) should be determined in every patient with signs and symptoms suggestive of HF. We performed a community-based study to evaluate the diagnostic evaluation of patients with HF and/or HF risk factors carried out by primary care physicians. We screened the adult population of a small Polish town (5521 inhabitants). Inclusion criteria were as follows: age ≥ 55 years and either the diagnosis of HF or presence of at least one of the following HF risk factors: ischaemic heart disease and/or hypertension with complications and/or diabetes mellitus. A total of 218 patients who met the inclusion criteria were invited to participate in the study and 175 of them (80.3%) were evaluated and followed up for 58 ± 1 months. The diagnosis of HF was established in 38/175 patients (22%) (Group 1). The signs and symptoms of HF without the formal diagnosis of HF were present in 44/175 patients (25%) (Group 2) and 93/175 patients (53%) had neither HF nor its signs or symptoms (Group 3). During the follow-up, in some of patients from Groups 2 and 3, the diagnosis of HF was established and these patients crossed over to Group 1a. In 2009, there were 56 patients in Group 1a, 37 in Group 2a and 82 in Group 3a. At baseline, in years 2004/2005, echocardiograms were available in 37%, 25% and 17% of the patients in Groups 1, 2 and 3, respectively, chest radiograms in 86%, 54%, 58% of the patients, respectively, and BNP measurements in 5%, 5% and 0% of the patients, respectively. At the end of the follow-up we observed an increased number of diagnostic tests performed but the difference was not statistically significant. Our study showed a considerable discrepancy between the guidelines and primary practice and underscores the need to change the practical approach to diagnostic investigations, especially echocardiography and BNP measurements in HF patients.